The presence or absence of autoantibodies in patients with rheumatoid arthritis (RA) can guide clinical practice, but the role of autoantibody status in 'real life' is unclear. A cohort study from Canada provides clinical perspective on the presentation, prognosis and efficacy of treatment of patients with autoantibody-negative RA.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
High-frequency ultrasound in patients with seronegative rheumatoid arthritis
Scientific Reports Open Access 09 December 2022
-
Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings
Clinical Reviews in Allergy & Immunology Open Access 08 September 2021
-
Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study
Rheumatology International Open Access 16 August 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Willemze, A., Trouw, L. A., Toes, R. E. & Huizinga, T. W. The influence of ACPA status and characteristics on the course of RA. Nat. Rev. Rheumatol. 8, 144–152 (2012).
Barra, L. et al. Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis. J. Rheumatol. http://dx.doi.org/10.3899/jrheum.140082.
De Punder, Y. M. et al. Should we redefine treatment targets in rheumatoid arthritis? Low disease activity is sufficiently strict for patients who are anticitrullinated protein antibody-negative. J. Rheumatol. 40, 1268–1274 (2013).
Van den Broek, M. et al. The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study. Ann. Rheum. Dis. 71, 245–248 (2012).
Van der Woude, D. et al. Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies. Rheumatology (Oxford) 51, 1120–1128 (2012).
Seegobin, S. D. et al. ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial. Arthritis Res. Ther. 16, R13 (2014).
Wevers-de Boer, K. et al. Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study). Ann. Rheum. Dis. 71, 1472–1477 (2012).
De Rooy, D. P., Willemze, A., Mertens, B., Huizinga, T. W. & Van der Helm-van Mil, A. H. Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes? Arthritis Res. Ther. 13, R180 (2011).
Trouw, L. A., Huizinga, T. W. & Toes, R. E. Autoimmunity in rheumatoid arthritis: different antigens—common principles. Ann. Rheum. Dis. 72 (Suppl. 2), ii132–ii136 (2013).
Shi, J. et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl Acad. Sci. USA 108, 17372–17377 (2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ajeganova, S., Huizinga, T. Seronegative and seropositive RA: alike but different?. Nat Rev Rheumatol 11, 8–9 (2015). https://doi.org/10.1038/nrrheum.2014.194
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2014.194
This article is cited by
-
High-frequency ultrasound in patients with seronegative rheumatoid arthritis
Scientific Reports (2022)
-
Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study
Rheumatology International (2022)
-
Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings
Clinical Reviews in Allergy & Immunology (2021)
-
Cardiovascular risk in patients with rheumatoid arthritis
Seminars in Immunopathology (2017)
-
Long-term outcomes of destructive seronegative (rheumatoid) arthritis – description of four clinical cases
BMC Musculoskeletal Disorders (2016)